Immunohistochemical analysis showed that H3K18la and KRT19 levels were significantly elevated, but p21 expression was decreased in clinical NSCLC specimens compared with adjacent normal tissues (Fig. 8A-D). This evidence concerns the gene CDKN1A and non-small cell lung carcinoma.